Drug Type Small molecule drug |
Synonyms JX35 |
Target |
Mechanism PfHDAC1 inhibitors(Plasmodium falciparum HDAC1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H24ClN7O2 |
InChIKeyNPDHHPIUUWFZPB-UHFFFAOYSA-N |
CAS Registry2482998-35-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria | Preclinical | CN | 17 Feb 2022 |